Nephrocare Health Services Limited
ListedMainboardHealthcare · NSE / BSE
Incorporated in 2010, Nephrocare Health Services Ltd. provides comprehensive dialysis care through an extensive network of clinics across India and select international markets. As of March 31, 2025, the company operated 490 clinics—447 in India and 43 across the Philippines, Uzbekistan, and Nepal—including the world’s largest dialysis clinic in Uzbekistan. Nephrocare serves 269 cities across 21 states and 4 union territories, with nearly 77% of its centers located in tier II and III regions to improve access for underserved populations. In FY 2025, it treated 29,281 patients and delivered over 2.88 million dialysis sessions, representing about 10% of India’s dialysis patient base. The company managed 5,068 dialysis machines by March 2025, demonstrating consistent growth over prior years. Nephrocare has also partnered with leading hospital chains such as Max, Fortis Escorts, Care Hospitals, Wockhardt, Paras, CMRI, Jehangir Hospital, and Ruby Hall Clinic to operate in-house dialysis centers and enhance service reach.
Price Band
₹438 – ₹460
Issue Size
₹871 Cr
Lot Size
32 shares
GMP
₹36
+7.8%
Est. Listing
₹496
at current GMP
Subscribed
14.08x
overall
Open
10 Dec 2025
Close
12 Dec 2025
Allotment
15 Dec 2025
Refund
16 Dec 2025
Demat Credit
17 Dec 2025
Listing
17 Dec 2025
Last updated 12 days ago
Overall Subscription
14.08x
Total Demand
QIB Multiplier
26.82x
Institutions & Funds
NII / HNI
24.77x
High Net-Worth
Retail (RII)
2.35x
Individual Bidders
Category-Wise Subscription Breakup
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| QIB | 3,768,224 | 101,069,088 | 26.82x |
| NIB | 2,827,843 | 70,052,352 | 24.77x |
| HNIs(10L +) | 1,885,229 | 57,366,080 | 30.43x |
| HNIs (2-10L) | 942,614 | 12,686,272 | 13.46x |
| RETAIL | 6,598,301 | 15,538,304 | 2.35x |
| EMPLOYEES | 83,532 | 235,136 | 2.81x |
| Total | 16,105,743 | 256,947,232 | 14.08x |
Application-Wise Breakup
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| RETAIL | 206,197 | 401,889 | 1.95x |
| EMPLOYEES | — | 3,820 | 0.00x |
| HNIs(10L +) | 4,208 | 25,725 | 6.11x |
| HNIs (2-10L) | 2,104 | 27,685 | 13.16x |
| Total Applications | 212,509 | 459,119 | 2.16x |
Day-Wise Subscription Progress
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
About Nephrocare Health Services Limited Public Issue & Market Profile
Nephrocare Health Services Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹871.05 Crores. The shares are offered at a price band of ₹438 to ₹460 per equity share on NSE and BSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Bidding & Quota Instructions:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 32 shares (approx. ₹14,720 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment Reconciliation Schedule:
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-12-17, while un-allotted funds or UPI block mandates will be released on 2025-12-16.
Frequently Asked Questions
What is Nephrocare Health Services Limited IPO GMP today?
The latest Grey Market Premium (GMP) for Nephrocare Health Services Limited IPO is ₹36 per equity share. Based on the upper price band of ₹438 to ₹460 per equity share, the estimated listing price is ₹496 (+7.8% expected listing gain).
What is the expected profit per lot for Nephrocare Health Services Limited IPO?
With a lot size of 32 shares and current GMP of ₹36, the expected profit per application lot is approx ₹1,152 (+7.8% gain). Minimum application cost is approx ₹14,720.
What is the issue size and price band for Nephrocare Health Services Limited IPO?
The Nephrocare Health Services Limited IPO aggregate issue size is ₹871.05 Crores with an equity price band set at ₹438 to ₹460 per equity share. The retail lot size is 32 shares requiring a minimum capital outlay of approx. ₹14,720.
How can I check Nephrocare Health Services Limited IPO live subscription demand?
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 14.08x (Retail: 2.35x, QIB: 26.82x, NII: 24.77x). You can track live multiples directly on our dedicated subscription page.
Where and when will Nephrocare Health Services Limited IPO allotment status be published?
The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2025-12-15. Investors can verify status using PAN card or application number.
When is the listing date for Nephrocare Health Services Limited IPO?
Nephrocare Health Services Limited shares are scheduled to list on NSE and BSE on 2025-12-17.